Global Irritable Bowel Syndrome (IBS) Market Size, Manufacturers, Opportunities and Forecast to 2030
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
According to APO Research, The global Irritable Bowel Syndrome (IBS) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome (IBS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome (IBS).
The Irritable Bowel Syndrome (IBS) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irritable Bowel Syndrome (IBS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irritable Bowel Syndrome (IBS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Irritable Bowel Syndrome (IBS) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irritable Bowel Syndrome (IBS).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Irritable Bowel Syndrome (IBS) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Chapter 12: Concluding Insights of the report
According to APO Research, The global Irritable Bowel Syndrome (IBS) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome (IBS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome (IBS).
The Irritable Bowel Syndrome (IBS) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irritable Bowel Syndrome (IBS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Bausch Health
- Allergan
- Takeda
- Sucampo Pharmaceuticals (Mallinckrodt)
- Sebela Pharmaceuticals Inc
- Astellas Pharmaceuticals
- IBS-D Drug
- IBS-C Drug
- Others
- Women
- Men
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irritable Bowel Syndrome (IBS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Irritable Bowel Syndrome (IBS) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irritable Bowel Syndrome (IBS).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Irritable Bowel Syndrome (IBS) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Irritable Bowel Syndrome (IBS) Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Irritable Bowel Syndrome (IBS) Market Size by Region (2019-2030)
1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region (2019-2024)
1.4.2 Global Irritable Bowel Syndrome (IBS) Market Size by Region (2025-2030)
1.5 Key Regions Irritable Bowel Syndrome (IBS) Market Size (2019-2030)
1.5.1 North America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2019-2030)
1.5.2 Europe Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2019-2030)
1.5.4 Latin America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2019-2030)
2 IRRITABLE BOWEL SYNDROME (IBS) MARKET BY TYPE
2.1 Type Introduction
2.1.1 IBS-D Drug
2.1.2 IBS-C Drug
2.1.3 Others
2.2 Global Irritable Bowel Syndrome (IBS) Market Size by Type
2.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Overview by Type (2019-2030)
2.2.2 Global Irritable Bowel Syndrome (IBS) Historic Market Size Review by Type (2019-2024)
2.2.3 Global Irritable Bowel Syndrome (IBS) Market Size Forecasted by Type (2025-2030)
2.3 Global Irritable Bowel Syndrome (IBS) Market Size by Regions
2.3.1 North America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2019-2024)
3 IRRITABLE BOWEL SYNDROME (IBS) MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Women
3.1.2 Men
3.2 Global Irritable Bowel Syndrome (IBS) Market Size by Application
3.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Overview by Application (2019-2030)
3.2.2 Global Irritable Bowel Syndrome (IBS) Historic Market Size Review by Application (2019-2024)
3.2.3 Global Irritable Bowel Syndrome (IBS) Market Size Forecasted by Application (2025-2030)
3.3 Global Irritable Bowel Syndrome (IBS) Market Size by Regions
3.3.1 North America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Irritable Bowel Syndrome (IBS) Industry Trends
4.2 Irritable Bowel Syndrome (IBS) Industry Drivers
4.3 Irritable Bowel Syndrome (IBS) Industry Opportunities and Challenges
4.4 Irritable Bowel Syndrome (IBS) Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Irritable Bowel Syndrome (IBS) Revenue (2019-2024)
5.2 Global Irritable Bowel Syndrome (IBS) Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Irritable Bowel Syndrome (IBS) Key Company Headquarters & Area Served
5.4 Global Irritable Bowel Syndrome (IBS) Company, Product Type & Application
5.5 Global Irritable Bowel Syndrome (IBS) Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Irritable Bowel Syndrome (IBS) Market CR5 and HHI
5.6.2 Global Top 5 and 10 Irritable Bowel Syndrome (IBS) Players Market Share by Revenue in 2023
5.6.3 2023 Irritable Bowel Syndrome (IBS) Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Bausch Health
6.1.1 Bausch Health Comapny Information
6.1.2 Bausch Health Business Overview
6.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Product Portfolio
6.1.5 Bausch Health Recent Developments
6.2 Allergan
6.2.1 Allergan Comapny Information
6.2.2 Allergan Business Overview
6.2.3 Allergan Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Allergan Irritable Bowel Syndrome (IBS) Product Portfolio
6.2.5 Allergan Recent Developments
6.3 Takeda
6.3.1 Takeda Comapny Information
6.3.2 Takeda Business Overview
6.3.3 Takeda Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Takeda Irritable Bowel Syndrome (IBS) Product Portfolio
6.3.5 Takeda Recent Developments
6.4 Sucampo Pharmaceuticals (Mallinckrodt)
6.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Comapny Information
6.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
6.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Portfolio
6.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
6.5 Sebela Pharmaceuticals Inc
6.5.1 Sebela Pharmaceuticals Inc Comapny Information
6.5.2 Sebela Pharmaceuticals Inc Business Overview
6.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Portfolio
6.5.5 Sebela Pharmaceuticals Inc Recent Developments
6.6 Astellas Pharmaceuticals
6.6.1 Astellas Pharmaceuticals Comapny Information
6.6.2 Astellas Pharmaceuticals Business Overview
6.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Portfolio
6.6.5 Astellas Pharmaceuticals Recent Developments
7 NORTH AMERICA
7.1 North America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
7.3 North America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
8.3 Europe Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
9.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
10.3 Latin America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
11.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Irritable Bowel Syndrome (IBS) Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Irritable Bowel Syndrome (IBS) Market Size by Region (2019-2030)
1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region (2019-2024)
1.4.2 Global Irritable Bowel Syndrome (IBS) Market Size by Region (2025-2030)
1.5 Key Regions Irritable Bowel Syndrome (IBS) Market Size (2019-2030)
1.5.1 North America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2019-2030)
1.5.2 Europe Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2019-2030)
1.5.4 Latin America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2019-2030)
2 IRRITABLE BOWEL SYNDROME (IBS) MARKET BY TYPE
2.1 Type Introduction
2.1.1 IBS-D Drug
2.1.2 IBS-C Drug
2.1.3 Others
2.2 Global Irritable Bowel Syndrome (IBS) Market Size by Type
2.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Overview by Type (2019-2030)
2.2.2 Global Irritable Bowel Syndrome (IBS) Historic Market Size Review by Type (2019-2024)
2.2.3 Global Irritable Bowel Syndrome (IBS) Market Size Forecasted by Type (2025-2030)
2.3 Global Irritable Bowel Syndrome (IBS) Market Size by Regions
2.3.1 North America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2019-2024)
3 IRRITABLE BOWEL SYNDROME (IBS) MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Women
3.1.2 Men
3.2 Global Irritable Bowel Syndrome (IBS) Market Size by Application
3.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Overview by Application (2019-2030)
3.2.2 Global Irritable Bowel Syndrome (IBS) Historic Market Size Review by Application (2019-2024)
3.2.3 Global Irritable Bowel Syndrome (IBS) Market Size Forecasted by Application (2025-2030)
3.3 Global Irritable Bowel Syndrome (IBS) Market Size by Regions
3.3.1 North America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Irritable Bowel Syndrome (IBS) Industry Trends
4.2 Irritable Bowel Syndrome (IBS) Industry Drivers
4.3 Irritable Bowel Syndrome (IBS) Industry Opportunities and Challenges
4.4 Irritable Bowel Syndrome (IBS) Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Irritable Bowel Syndrome (IBS) Revenue (2019-2024)
5.2 Global Irritable Bowel Syndrome (IBS) Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Irritable Bowel Syndrome (IBS) Key Company Headquarters & Area Served
5.4 Global Irritable Bowel Syndrome (IBS) Company, Product Type & Application
5.5 Global Irritable Bowel Syndrome (IBS) Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Irritable Bowel Syndrome (IBS) Market CR5 and HHI
5.6.2 Global Top 5 and 10 Irritable Bowel Syndrome (IBS) Players Market Share by Revenue in 2023
5.6.3 2023 Irritable Bowel Syndrome (IBS) Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Bausch Health
6.1.1 Bausch Health Comapny Information
6.1.2 Bausch Health Business Overview
6.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Product Portfolio
6.1.5 Bausch Health Recent Developments
6.2 Allergan
6.2.1 Allergan Comapny Information
6.2.2 Allergan Business Overview
6.2.3 Allergan Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Allergan Irritable Bowel Syndrome (IBS) Product Portfolio
6.2.5 Allergan Recent Developments
6.3 Takeda
6.3.1 Takeda Comapny Information
6.3.2 Takeda Business Overview
6.3.3 Takeda Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Takeda Irritable Bowel Syndrome (IBS) Product Portfolio
6.3.5 Takeda Recent Developments
6.4 Sucampo Pharmaceuticals (Mallinckrodt)
6.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Comapny Information
6.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
6.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Portfolio
6.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
6.5 Sebela Pharmaceuticals Inc
6.5.1 Sebela Pharmaceuticals Inc Comapny Information
6.5.2 Sebela Pharmaceuticals Inc Business Overview
6.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Portfolio
6.5.5 Sebela Pharmaceuticals Inc Recent Developments
6.6 Astellas Pharmaceuticals
6.6.1 Astellas Pharmaceuticals Comapny Information
6.6.2 Astellas Pharmaceuticals Business Overview
6.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Portfolio
6.6.5 Astellas Pharmaceuticals Recent Developments
7 NORTH AMERICA
7.1 North America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
7.3 North America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
8.3 Europe Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
9.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
10.3 Latin America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
11.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
